1-888-210-9968 • 24/7 1-888-210-9968 • 24/7 GET FREE ADVICE
The call is free. The advice is free.
Looking for Answers?

Have you or your son developed gynecomastia, or breast growth after taking Risperdal?

Wondering about your legal options?

We can help.  Contact us to find out the deadline for filing a claim in the United States.

Free Case Review

  • This field is for validation purposes and should be left unchanged.

You pay us nothing unless we win your case.

  • You Have Questions
  • We Have Answers
  • We Get Results

Risperdal Gynecomastia Trial Awards $1.75M For Breast Growth and Mental Anguish

Written by on November 10, 2015

According to Bloomberg, the latest Risperdal gynecomastia lawsuit trial has awarded $1.75M to the plaintiff, including damages for disfigurement and mental anguish. The plaintiff, Tim Stange, alleged he experienced unnatural breast growth as a result of taking Risperdal. His neurologist, the doctor who prescribed the drug, claims he would not have done so had he been made aware of the gynecomastia risk.

Risperdal Breast Growth Lawsuits Scheduled For Trial In October, 2015

Written by on September 1, 2015

Approved for sale by the FDA in 1994, Risperdal is prescribed to treat a variety of mental illnesses, from schizophrenia to bipolar disorder. It’s one of the most popular antipsychotics prescribed to kids. Unfortunately, according to thousands of families, the drug caused their adolescent boys to experience gynecomastia, or male breast enlargement. Today, more than 1,400 Risperdal lawsuits are pending in a fast-growing mass tort in Philadelphia.

Risperdal Settlement 2015: Johnson & Johnson Settles Risperdal Breast Growth Lawsuit Just Hours Before Trial

Written by on May 28, 2015

The third in a series of Risperdal Gynecomastia Lawsuit bellwether trials reportedly settled today, just hours before it was scheduled to be heard in a Pennsylvania court. According to a spokesperson at Janssen Pharmaceuticals (a division of Johnson & Johnson), the undisclosed Risperdal lawsuit settlement amount with plaintiff Christopher Walker was confidential.

Risperdal Gynecomastia Lawsuits in 2015 Reveal Manufacturer’s Pursuit Of Profit Over Young Boys’ Safety

Written by on May 12, 2015

For many parents, the atypical antipsychotic Risperdal seems like a godsend. It can help mitigate troublesome behavior in autistic children. Some parents with kids who are severely autistic rely on the drug to bring a sense of normalcy and predictability to their lives. But use of the medication isn’t without possible side effects. Scientific evidence has repeatedly shown a potential connection between Risperdal and abnormal breast enlargement in young boys.

Why Are Enraged Parents Filing Risperdal Lawsuit Claims On Behalf Of Their Sons?

Written by on April 21, 2015

Approximately 1 year ago, Johnson & Johnson settled charges of illegal marketing of its antipsychotic Risperdal. The charges arose from an investigation launched by the U.S. Department of Justice. The drug maker agreed to pay $2.2 billion to end the investigation. But that wasn’t the end of J&J’s legal troubles involving the antipsychotic. It’s currently facing hundreds of Risperdal gynecomastia lawsuit claims filed by angered parents.

How Much Is A Risperdal Gynecomastia Lawsuit Settlement Worth?

Written by on March 3, 2015

Johnson & Johnson is under increasing scrutiny for failing to warn families about the possible connection between its drug Risperdal and breast development in young boys. Many families have learned the hard way that trusting the pharmaceutical giant’s claim that its antipsychotic medicine is safe presents an enormous risk. Hundreds of Risperdal breast growth lawsuit claims have been filed on behalf of adolescent males injured by the drug.

Risperdal Lawsuit 2015: Jury Awards $2.5 Million in Damages For Failure To Warn Of Gynecomastia Risk

Written by on February 25, 2015

A Philadelphia jury awarded $2.5 million in damages yesterday, February 24, 2015. Johnson & Johnson was accused of failing to warn that Risperdal causes gynecomastia, or male breast growth, in adolescents. This first Risperdal lawsuit in 2015 marks the beginning of a series of trials intended to determine if J&J knew about the risks associated with Risperdal. Expert witness David Kessler testified that the pharmaceutical company knew about the risk and failed to disclose the data showing the extent of that risk.

Ex-FDA Chief Tesitimony: J&J Knew About Risperdal Link to Male Breast Growth in Adolescents

Written by on February 5, 2015

Former FDA Chief David Kessler testified in Philadelphia state court for the plaintiff over the allegations that Risperdal causes male breast growth. According to Bloomberg Business News, Kessler told the jury that officials of J&J’s Janssen unit funded a 2001 study that showed 3.8 percent of boys given Risperdal during the clinical trial developed breasts that were either “probably or very likely” caused by the drug.

Risperdal Breast Growth Lawsuits Consolidated In Philadelphia

Written by on February 1, 2015

Many parents with children coping with attention deficit hyperactivity disorder (ADHD), bipolar disorder, autism or severe aggression have put their trust in the antipsychotic medication Risperdal. Manufactured by Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), the drug is marketed as a safe and effective treatment for a range of mood-related disorders. But reports of abnormal breast growth among young boys taking it have prompted a wave of parents seeking Risperdal class action lawsuits.

J&J Settles A Risperdal Lawsuit Claim As Male Plaintiff Alleges Breast Development

Written by on January 8, 2015

Risperdal male breast development is no laughing matter, especially for the young men and boys who are coping with the problem. Known as gynecomastia, the disorder often has a negative psychological impact on those suffering from it. A growing number of families are learning this firsthand. Husbands, fathers, and sons using the antipsychotic drug Risperdal have reported growing breasts – in some cases, as large as a C or D-cup.

Risperdal Lawsuit FAQ: Answers To Common Questions Asked By Risperdal Gynecomastia Victims

Written by on November 25, 2014

Families with one or more members using Risperdal are understandably concerned regarding news that the drug can cause serious side effects. A growing number of men and young boys have reportedly developed diabetes, movement problems, and gynecomastia (male breast growth) after using it. Worse, the drug is oftentimes prescribed for “off-label” uses, exposing thousands of people to potentially permanent Risperdal side effects.

Should You Join A Risperdal Class Action Lawsuit?

Written by on November 18, 2014

Approved by the FDA in 1994, Johnson & Johnson’s antipsychotic drug Risperdal is prescribed to treat schizophrenia, bipolar disorder, and other mental illnesses. In 2006, the drug was approved for children. But studies show that its use might not be without risks. Many children have developed severe side effects after using Risperdal. Their families are now suing J&J, alleging it failed to adequately inform them of the dangers.

Bellwether Risperdal Gynecomastia Lawsuits Scheduled To Begin In November

Written by on October 10, 2014

Parents of young boys who have experienced abnormal breast growth after taking the antipsychotic medication Risperdal may soon have something to smile about. A number of lawsuits accusing the manufacturer, Johnson & Johnson, of failing to warn parents about the risk have been scheduled for a late-2014, early-2015 trial date. These first cases will serve as bellwether trials. They could pave the way for a Risperdal lawsuit settlement with other claimants.

Controversy Over Arkansas $1.2 Billion Risperdal Lawsuit Award

Written by on June 5, 2014

Lawsuits over the antipsychotic Risperdal continue to be filed on behalf of families who are reeling from the drug’s potential side effects. Male children have reportedly developed breasts, a condition known as gynecomastia, after using it. Claimants have accused Johnson & Johnson, along with its Janssen unit, for failing to adequately warn the public. Many of the lawsuits further allege that J&J and Janssen intentionally misled consumers and the medical community with regard to the drug’s risks.

Risperdal Settlement Reached for Five Risperdal Lawsuits

Written by on December 9, 2013

In the fall of 2013, Johnson & Johnson agreed to settle lawsuits brought by 5 families whose sons used the antipsychotic drug Risperdal. These families alleged that their children had developed male breasts, a condition known as gynecomastia, as the result of using Risperdal. They also accused J&J of failing to adequately warn about the risk of this condition associated with its drug.

Nationwide Claims Help

Click on your state for more information or call 1-888-210-9968.